Status:
COMPLETED
Efficacy of Acupuncture in Exercise Tolerance in Patients With COPD
Lead Sponsor:
Instituto de Ciências Biomédicas Abel Salazar
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is nowadays the 4th cause of death in the world and it´s expected to become the 3rd cause of death in 2020 and the majority cause of morbidity. Besides tha...
Eligibility Criteria
Inclusion
- COPD GOLD III,IV;
- able to walk;
- Informed consent signed;
- stable medication during last 3 days
- exacerbation during 3 months;
- Chinese diagnose opening principle;
- blood pressure "90"180 mmhg/ "100mmhg; respiratory rate "10"30 cpm
Exclusion
- smoker;
- metastasis;
- hepatic,
- renal or cardiovascular disease;
- pulmonary hypertension;
- COPD symptoms exacerbation during the therapy;
- previous acupuncture treatments;
- unstable vital signs;
- pulmonary rehabilitation in the last 6 months;
- needle phobia.
Key Trial Info
Start Date :
June 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2018
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03767140
Start Date
June 27 2018
End Date
November 28 2018
Last Update
December 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carla Manuela Loureiro Barros
Marco de Canaveses, Porto District, Portugal, 4635 670